medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2024, Number 5

<< Back Next >>

Arch Med Fam 2024; 26 (5)

Factors Associated with Complications in Patients with Type 2 Diabetes Mellitus in Primary Care

Casillas MÁI, Vázquez MVH, Martínez-Bautista H, Muñoz VP, Morales SE

Language: Spanish
References: 22
Page: 223-230
PDF size: 348.40 Kb.


Text Extraction

Objective: To determine the risk factors associated with type 2 diabetes mellitus complications in a primary care. Methods: Observational, cross-sectional, and retrospective study, carried out on 162 patients diagnosed with T2DM from a Family Medicine Unit in Reynosa, Mexico. The data were analyzed using univariate frequency and dispersion analysis; bivariate analysis with polychoric or polyserial correlations, depending on the type of data. Finally, a multinomial logistic regression model (MRLM) with Bootstrap was adjusted to identify the risk factors associated with complications. Results: 58% (94) of the participants were women and 42% (68) men, with an age average of 61.67 years and an average of 16 year since diagnosis; 39% of the participants were overweight: 31.5% had grade I obesity and 13.58% had grade II and III obesity. The average fasting blood glucose was 163 mg/dL and glycosylated hemoglobin was 7.97%. The two main risk factors associated with complications were: blood glucose level and time of onset of T2DM. Conclusions: The percentage of complications in patients with T2DM was high, so it is crucial to focus on two factors. First of all: timely control of glycemia at the beginning of the disease is essential to reduce the probability of complications. Second, the duration of the disease. This research identifies the importance of these risk factors and highlights key strategies aimed at reducing the occurrence of complications related to T2DM, which is expected to benefit the population of the northern region of Mexico.


REFERENCES

  1. Standl E, Khunti K, Hansen TB, Schnell O. The globalepidemics of diabetes in the 21st century: Currentsituation and perspectives. Eur J Prev Cardiol. 2019;26(2_suppl):7-14.

  2. Basto-Abreu A, López-Olmedo N, Rojas-Martínez R,Aguilar-Salinas CA, Moreno-Banda GL, Carnalla M,Rivera JA, Romero-Martínez M, Barquera S, Barrientos-Gutiérrez T. Prevalencia de prediabetes y diabetesen México: Ensanut 2022. Salud Publica Mex.2023;65(supl 1):S163-S168.

  3. López-Navarro JM, Pérez-Díaz IP, Valladares-Pérez EJ,Sánchez-Landa E, Staufert-Gutiérrez JR, Vega-Bey. RevMex Endocrinol Metab Nutr. 2018;5:115-24.

  4. Yahaya JJ, Doya IF, Morgan ED, Ngaiza AI, BintabaraD. Mal control glucémico y factores asociados entrepacientes con diabetes mellitus tipo 2: un estudiotransversal. Sci Rep. 2023 14 de junio; 13(1):9673. doi:10.1038/s41598-023-36675-3. PMID: 37316565; PMCID:PMC10267215.

  5. Ovalle-Luna Oscar David, Jiménez-Martínez Iván Abimael,Rascón-Pacheco Ramón Alberto, Gómez-DíazRita A., Valdez-González Adriana L., Gamiochipi-CanoMireya et al . Prevalencia de complicaciones dela diabetes y comorbilidades asociadas en medicinafamiliar del Instituto Mexicano del Seguro Social. Gac.Méd. Méx [revista en la Internet]. 2019 Feb [citado2024 Ago 30] ; 155( 1 ): 30-38. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132019000100030&lng=es. Epub 01-Jul-2021. https://doi.org/10.24875/gmm.18004486.Ovalle-Luna OD, et al: Complicaciones de la diabetes en elIMSS, México. Gaceta Médica de México. 2019;155:30-38.

  6. Sánchez-Pozos K, Monroy-Escutia J, Jaimes-Santoyo J,Granados-Silvestre MLÁ, Menjivar M, Ortiz-López MG.Risk factors associated with diabetic neuropathy inMexican patients. Cir Cir. 2021;89(2):189-199.

  7. Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and riskfactors of diabetic retinopathy in diabetic patients:A community based cross-sectional study. Medicine(Baltimore). 2020;99(9):e19236.

  8. Ma Y, Wang H, Jiang J, et al. Prevalence of and riskfactors for diabetic retinopathy in residents with differenttypes of abnormal glucose metabolism with orwithout hypertension: A suburban community-basedcross-sectional study. Front Endocrinol (Lausanne).2022;13:966619.

  9. Sen S, Ramasamy K, Vignesh TP, et al. Identificationof risk factors for targeted diabetic retinopathy screeningto urgently decrease the rate of blindness inpeople with diabetes in India. Indian J Ophthalmol.2021;69(11):3156-3164.

  10. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas:Global, regional and country-level diabetes prevalenceestimates for 2021 and projections for 2045 [publishedcorrection appears in Diabetes Res Clin Pract.2023 Oct;204:110945].

  11. Rooney MR, Fang M, Ogurtsova K, et al. Global Prevalenceof Prediabetes. Diabetes Care. 2023;46(7):1388-1394.

  12. Coutiño-Escamilla, L. Panorama epidemiológico de ladiabetes tipo 2 en la frontera norte de México. Avancede Investigación. El Colegio de Sonora. (2021).

  13. Shamah-Levy T, Romero-Martínez M, Barrientos-GutiérrezT, Cuevas-Nasu L, Bautista-Arredondo S, ColcheroMA, GaonaPineda EB, Lazcano-Ponce E, Martínez-Barnetche J, Alpuche-Arana C, Rivera-DommarcoJ. Encuesta Nacional de Salud y Nutrición 2020 sobreCovid-19. Resultados nacionales. Cuernavaca, México:Instituto Nacional de Salud Pública, 2021.

  14. Fagerland M, Hosmer D. A Generalized Hosmer–LemeshowGoodness-of-Fit Test for Multinomial LogisticRegression Models. Stata Journal. 2012;12:447–53.

  15. Jalilian H, Javanshir E, Torkzadeh L, et al. Prevalenceof type 2 diabetes complications and its associationwith diet knowledge and skills and self-care barriersin Tabriz, Iran: A cross-sectional study. Health Sci Rep.2023;6(2):e1096.

  16. Hafidh K, Malek R, Al-Rubeaan K, et al. Prevalenceand risk factors of vascular complications in type2 diabetes mellitus: Results from discover MiddleEast and Africa cohort. Front Endocrinol (Lausanne).2022;13:940309.

  17. El Alami H, Haddou I, Benaadi G, et al. Prevalence andrisk factors of chronic complications among patientswith type 2 diabetes mellitus in Morocco: a cross-sectionalstudy. Pan Afr Med J. 2022;41:18.

  18. Yin L, Zhang D, Ren Q, Su X, Sun Z. Prevalence and riskfactors of diabetic retinopathy in diabetic patients:A community based cross-sectional study. Medicine(Baltimore). 2020;99(9):e19236.

  19. Sun Q, Jing Y, Zhang B, et al. The Risk Factors for DiabeticRetinopathy in a Chinese Population: A Cross-SectionalStudy. J Diabetes Res. 2021;2021:5340453.

  20. Russo MP, Grande-Ratti MF, Burgos MA, Molaro AA,Bonella MB. Prevalence of diabetes, epidemiologicalcharacteristics and vascular complications. Prevalenciade diabetes, características epidemiológicasy complicaciones vasculares. Arch Cardiol Mex.2023;93(1):30-36.

  21. Sánchez-Pozos K, Monroy-Escutia J, Jaimes-Santoyo J,Granados-Silvestre MLÁ, Menjivar M, Ortiz-López MG.Factores de riesgo asociados a neuropatía diabéticaen pacientes mexicanos. Cir Cir. 2021;89(2):189-199.

  22. Ceriello A, Prattichizzo F. Variability of risk factorsand diabetes complications. Cardiovasc Diabetol.2021;20(1):101. doi: 10.1186/s12933-021-01289-4.PMID: 33962641; PMCID: PMC8106175.




2020     |     www.medigraphic.com